Zami Aberman
Chairman & Co-CEO,
Pluristem Therapeutics
Usman Azam
Chief Executive Officer,
Tmunity Therapeutics
Ron Bartek
Co-Founder and President,
Friedreich's Ataxia Research Alliance
Joanne Beck
EVP, Global Pharmaceutical Development and Operations,
Celgene Corporation
James Burns
President and CEO,
Casebia Therapeutics
Amy Butler
VP and GM Cell Biology,
Thermo Fisher Scientific
Deborah Dean
Executive Vice President & Chief Compliance Officer,
MiMedx
Flagg Flanagan
Chairman and CEO,
DiscGenics
Miguel Forte
CEO ,
Zelluna Immunotherapy
Adam Gridley
President and CEO,
Histogenics
Kristen Harrington-Smith
VP and Head, CAR-T US,
Novartis Oncology
Michael Hunt
Chief Financial Officer,
ReNeuron
Paul Laikind
President & CEO,
ViaCyte
Bruce Levine
Founding Director, Clinical Cell and Vaccine Production Facility,
Abramson Cancer Center, University of Pennsylvania
Michael May
President & Chief Executive Officer,
Centre for Commercialization of Regenerative Medicine (CCRM)
Claudia Mitchell
COO,
Universal Cells, An Astellas Company
Emile Nuwaysir
President & Chief Executive Officer,
BlueRock Therapeutics
Matt Patterson
CEO,
Audentes Therapeutics
Derrell Porter
SVP, Global Commercial Head,
Atara Biotherapeutics
Isabelle Riviere
Director, Cell Therapy and Cell Engineering Facility,
Memorial Sloan Kettering Cancer Center
Sanjaya Singh
Vice President and Global Head,
Janssen Pharmaceutical Companies of Johnson & Johnson, Janssen Research & Development
Donna Skerrett
Chief Medical Officer,
Mesoblast Limited
Devyn Smith
Chief Strategy Officer and Head of Operations,
Sigilon Therapeutics
Bob Smith
SVP, Global Gene Therapy Business,
Pfizer
Joe Tarnowski
SVP, Cell and Gene Therapy Platform,
GlaxoSmithKline
Keith Thompson
Chief Executive Officer,
Cell & Gene Therapy Catapult
Arthur Tzianabos
President and CEO,
Homology Medicines
Gil Van Bokkelen
President & CEO,
Athersys
Phil Vanek
General Manager, Cell Therapy Growth Strategies,
GE Healthcare LIfe Sciences
Jeffrey Walsh
Chief Financial and Strategy Officer,
bluebird bio
Susan Washer
President & CEO,
AGTC
Jason Wertheim
Assistant Professor of Surgery - Organ Transplantation, Department of Surgery, Institute for BioNanotechnology in Medicine, Feinberg School of Medicine and Chemistry of Life Processes Institute,
Northwestern University
